Astellas Pharma Global Development, Inc.

This study is testing a liquid form of the medicine mirabegron to see if it can help very young children (6 months to under 3 years old) with a nerve-related bladder condition. The goal is to see if the medicine safely increases how much urine the bladder can hold, which can redu…

This early-stage study is testing the safety of a new drug, zolbetuximab, when given alongside standard chemotherapy to people with advanced pancreatic cancer that has spread. The drug works by attaching to a specific protein on cancer cells to help the immune system attack the t…

This is a very early Phase 1 study to check the safety and side effects of a new injection called ASP2390 in adults who are allergic to house dust mites. The study will also measure if the injections change the body's immune response to the allergen. A small group of 28 participa…

This study is testing if adding a new drug called zolbetuximab to standard chemotherapy helps people with advanced pancreatic cancer that has spread. The drug works by targeting a specific protein found on many pancreatic cancer cells, aiming to help the immune system attack the …

This study tested whether adding the drug zolbetuximab to standard chemotherapy works better than chemotherapy alone for adults with advanced stomach or gastroesophageal (GEJ) cancer that has spread and cannot be removed by surgery. Zolbetuximab is designed to attach to a specifi…

This study is testing an experimental drug called zolbetuximab for people with advanced stomach or gastroesophageal junction cancer. The drug targets a specific protein (CLDN18.2) found on many of these tumors, aiming to flag them for the body's own immune system to attack. Resea…

This study is testing an experimental drug called enfortumab vedotin, both by itself and combined with other cancer therapies, for people with advanced bladder and urinary tract cancers. It aims to find safe doses and see if these treatments can shrink tumors. The study includes …

This study is testing whether adding the drug zolbetuximab to standard chemotherapy works better than chemotherapy alone for adults with advanced stomach or GEJ (where the food pipe meets the stomach) cancer that has spread and cannot be removed by surgery. The drug is designed t…

This study is testing a new combination of three oral and injectable drugs (gilteritinib, venetoclax, and azacitidine) for adults newly diagnosed with a fast-growing type of acute myeloid leukemia (AML) who are too old or have other health problems that make standard chemotherapy…

This study is testing an experimental drug called enfortumab vedotin, alone and in combination with pembrolizumab, in people with advanced solid tumors that have spread or returned after standard treatments. It aims to see if the treatment can shrink tumors and control the diseas…

This study follows 999 women experiencing bothersome hot flashes and night sweats during menopause. It observes their real-world experience after their doctor prescribes a non-hormonal medication. The main goal is to see if these symptoms improve after 12 weeks of treatment, whil…